Please wait
N/A0001936258N/AEX-FILING FEESNewAmsterdam Pharma Co N.V.Ordinary Shares, nominal value &#8364 0.12 per share, to be issued under the Incentive PlanOrdinary Shares, nominal value &#8364 0.12 per share, to be issued under the Incentive PlanOrdinary Shares, nominal value &#8364 0.12 per share, to be issued under the Inducement PlanOrdinary Shares, nominal value &#8364 0.12 per share, to be issued under the Inducement Plan000193625832026-02-182026-02-18000193625812026-02-182026-02-18000193625842026-02-182026-02-1800019362582026-02-182026-02-18000193625822026-02-182026-02-18xbrli:purexbrli:sharesiso4217:USD

Exhibit 107

 

CALCULATION OF FILING FEE TABLE

Form S-8

(Form Type)

NewAmsterdam Pharma Company N.V.

(Exact Name of Registrant as Specified in its Charter)

Table 1 - Newly Registered Securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Security Type

 

Security Class

Title

 

Fee Calculation
Rule

 

Amount

to be

Registered (1)

 

Proposed

Maximum

Offering
Price

Per Share
 

 

Proposed

Maximum

Aggregate

Offering

Price

 

Fee Rate

 

Amount of

Registration

Fee

 

 

 

 

 

 

 

 

Equity

 

Ordinary Shares, nominal value €0.12 per share, to be issued under the Incentive Plan

 

Rules 457(c) and 457(h)

 

4,325,529 (2)

 

$35.055 (3)

 

$151,631,419.10

 

$138.10 per $1,000,000

 

$20,940.30

Equity

 

Ordinary Shares, nominal value €0.12 per share, to be issued under the Incentive Plan

 

Rule 457(h)

 

1,394,437 (4)

 

$35.45 (5)

 

$49,432,791.65

 

$138.10 per $1,000,000

 

$6,826.67

Equity

 

Ordinary Shares, nominal value €0.12 per share, to be issued under the Inducement Plan

 

Rules 457(c) and 457(h)

 

742,691 (6)

 

$35.055 (3)

 

$26,035,033.01

 

$138.10 per $1,000,000

 

$3,595.44

Equity

 

Ordinary Shares, nominal value €0.12 per share, to be issued under the Inducement Plan

 

Rule 457(h)

 

257,309 (7)

 

$32.487 (8)

 

$8,359,197.48

 

$138.10 per $1,000,000

 

$1,154.41

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Offering Amounts

 

 

 

$235,458,441.24

 

 

 

$32,516.82

 

 

 

 

 

Total Fee Offsets (9)

 

 

 

 

 

 

 

$0

 

 

 

 

 

Net Fee Due

 

 

 

 

 

 

 

$32,516.82

 

(1)

Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover any additional ordinary shares in the share capital of NewAmsterdam Pharma Company N.V. (the “Company”), nominal value of €0.12 per share (the “Ordinary Shares”), that may become issuable under the Long-Term Incentive Plan NewAmsterdam Pharma Company N.V. (the “Incentive Plan”) and the Inducement Plan NewAmsterdam Pharma Company N.V. (the “Inducement Plan”) from time to time by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of the Company’s Ordinary Shares.

 

 

 

 

(2)

Represents Ordinary Shares reserved for issuance under the Incentive Plan and registered hereby, excluding Ordinary Shares registered hereby underlying option awards granted and outstanding under the Incentive Plan, as of the date of this Registration Statement. The Incentive Plan includes an “evergreen” provision, which provides that on each January 1st from January 1, 2023 through January 1, 2033, the number of Ordinary Shares available for issuance under the Incentive Plan will automatically increase annually in an amount equal to the lesser of five percent (5%) of the number of Ordinary Shares outstanding as of the close of business on the immediately preceding December 31st and the number of Ordinary Shares determined by the Company’s board of directors.

 

 

(3)

Estimated in accordance with Rule 457(c) and (h) under the Securities Act solely for the purpose of calculating the registration fee on the basis of $35.055, which was the average of the high and low prices of the Company’s Ordinary Shares as reported on The Nasdaq Global Market on February 13, 2026.

 

(4)

Represents Ordinary Shares registered hereby underlying option awards granted and outstanding under the Incentive Plan, as of the date of this Registration Statement.

 

(5)

Estimated in accordance with Rule 457(h) under the Securities Act solely for the purpose of calculating the registration fee on the basis of $35.45, which is weighted-average exercise price for options outstanding, but not registered, under the Incentive Plan, as of the date of this Registration Statement.

 

(6)

Represents Ordinary Shares reserved for issuance under the Inducement Plan and registered hereby, excluding Ordinary Shares registered hereby underlying option awards granted and outstanding under the Inducement Plan, as of the date of this Registration Statement.

 

 

(7)

Represents Ordinary Shares registered hereby underlying option awards granted and outstanding under the Inducement Plan, as of the date of this Registration Statement.

 

(8)

Estimated in accordance with Rule 457(h) under the Securities Act solely for the purpose of calculating the registration fee on the basis of $32.487, which is weighted-average exercise price for options outstanding, but not registered, under the Inducement Plan, as of the date of this Registration Statement.

 

(9)

The Registrant does not have any fee offsets.